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1. Introduction  
Angle-closure glaucoma is probably the first entity historically related with the Glaucomas. 
A large portion of global blindness is caused by angle-closure glaucoma, an estimated 3.9 
million blind persons for the year 2010 and a projected 5.3 million for 2020. Well over 20 
million people are estimated to become affected in the next ten years, with about 70% of the 
cases being women. (Quigley & Broman, 2006). 
Angle-closure glaucoma represents the second most common type of glaucoma, but its 
impact is more critical due to a greater likelihood of blindness than in patients with open-
angle glaucomas (Johnson & Foster, 2005). An accurate and timely diagnosis is essential, in 
order to start the appropriate and very specific treatment that may prevent progression to 
greater, irreversible damage. (Quigley & Broman, 2006). 
2. Definition 
Angle-closure glaucoma (ACG) includes a number of entities with closed angle, elevated 
intraocular pressure and optic nerve damage with corresponding visual field defects as 
common markers. These entities are characterised by iridotrabecular apposition, 
iridotrabecular synechiae or both.  
Depending on gonioscopy, intraocular pressure and optic nerve findings, we can 
distinguish 3 distinct categories of these entities: primary angle closure suspect, primary 
angle closure, and angle-closure glaucoma.  
In primary angle-closure, the trabecular meshwork can only be seen in 180º or less by 
gonioscopy, the intraocular pressure remains in normal limits and no structural damage to 
the optic nerve is present. Eyes with occludable angles have similar gonioscopic findings, 
intraocular pressure becomes elevated, but still no optic nerve damage is yet present 
(primary angle closure suspect). Additionally, angle-closure glaucoma eyes have evident 
signs of optic nerve damage. (European Glaucoma Society [EUGS], 2009). 
They can be further classified into primary and secondary forms. Primary angle-closure 
glaucoma occurs in an anatomically and functionally predisposed eye, it is not a 
consequence of other ocular or systemic abnormalities. 
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Secondary forms of angle-closure glaucoma are caused by other ocular or systemic 
abnormalities, such as uveitis, neovascular glaucoma, Marfan´s Syndrome or even some 
medications, such as Topiramate. (Yanoff  & Duker, 2004). 
3. Classification 
According to clinical presentation angle-closure glaucoma is classically classified in three 
types: acute, subacute or chronic. (Tasman & Jaeger,  2004). 
3.1 Acute angle-closure glaucoma  
This is probably the most frequent type of presentation. Acute ACG is estimated to 
represent 15% to 45% of all angle-closure glaucomas, (Friedman, 2001) and usually presents 
with a rapid onset of symptoms. The patient complains of ocular pain of varying severity: 
from deep, localized, ocular pain to a vaguely diffuse headache. The pain can sometimes be 
ignored by the patient, who becomes worried about other symptoms such as nausea and 
vomiting (vagal symptoms) often accompanying visual symptoms such as blurred vision, 
coloured halos around lights and visual loss.  
Reduced visual acuity, photophobia, conjunctival and ciliary congestion, corneal oedema 
and shallow peripheral anterior chamber with cells and flare are frequent findings. 
Intraocular pressure usually exceeds 40 mmHg. Other signs such as iris atrophy, posterior 
synechiae, glaukomflecken and structural optic nerve damage (cupping or pallor) are 
indicative of previous angle-closure glaucoma episodes.  
Poor visualization of anterior segment structures during an acute attack is very common, 
due to corneal oedema. If gonioscopy is feasible, central corneal compression with a four 
mirror gonioscopy lens (Forbes indentation technique) pushes aqueous to the peripheral 
anterior chamber, helping differentiate between appositional and synechial angle closure  
(Figures 4, A and B). These exploration manoeuvres should not be performed in very 
symptomatic patients, in whom the intraocular pressure is extremely elevated.  
Spontaneous resolution of an acute attack, although possible, is very rare; immediate 
medical and surgical treatment are often necessary.  
3.2 Subacute angle-closure glaucoma 
Symptoms in subacute ACG may be similar to those in acute angle-closure glaucoma, but of 
intermittent or lower intensity, and may spontaneously disappear. Symptoms may include: 
intermittent pain, headache, conjunctival and ciliary congestion, blurred vision and 
coloured halos around lights. The diagnosis is challenging, because of the spontaneous 
resolution after a couple of hours, and the possibility of confusion with other ocular or 
systemic diseases. It is important to be highly suspicious in order to make the correct 
diagnosis and improve prognosis with timely treatment. (Tasman & Jaeger, 2004). This 
particular group of patients are frequently confused with normal-tension glaucomas and 
non-arteritic anterior ischemic optic neuropathy, due to the presence of optic nerve cupping 
and sectorial pallor in a patient with IO in the normal range during the daytime. 
3.3 Chronic angle-closure glaucoma  
These type of ACG is characterized by the presence of peripheral anterior synechia (PAS) 
that close the angle in a variable extension confirmed by gonioscopy and Forbes indentation 
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technique. Progressive closure of the angle by PAS corresponds well with the increase in 
IOP. The patient may be asymptomatic until vision loss becomes evident, unless they are 
lucky enough to be diagnosed on a routine ophthalmologic examination. 
4. Angle anatomy 
In normal angles the following structures should be seen in gonioscopy: Schwalbe´s line, 
trabecular meshwork, scleral spur and the ciliary body band (Figure 1). Some other findings 
may be present in normal or abnormal angles. 
4.1 Schwalbe's line 
Schwalbe's line is the most anterior structure seen on gonioscopy. It is a collagen condensation 
of Descemet´s membrane, which lies between the corneal endothelium and the trabecular 
meshwork. It is normally seen as a thin, translucent line that protrudes into the anterior 
chamber. This prominence is quite variable and may have heavy pigmentation over it.  
4.2 Trabecular meshwork 
Continuing posterior to Schwalbe´s line is the trabecular meshwork. Its extends to the scleral 
spur, has a dull gray appearance and is somewhat translucent, except for a tenuous 
pigmentation of the lower half of the trabecular meshwork. Schlemm’s canal can be seen 
through it sometimes, when blood refluxes during gonioscopy.  
4.3 Scleral spur 
The next posterior structure is the scleral spur; a short extension of sclera forming the 
inferior wall of a scleral pocket where Schlemm's canal rests and the longitudinal ciliary 
muscle normally inserts. It appears white and opaque and is seen as a thin white line below 
the trabecular meshwork. 
4.4 Ciliary body band 
The ciliary body band is seen on gonioscopy below the scleral spur as a pale gray to dull 
brown band. The width of visible ciliary band will depend on the iris insertion, and this fact 
makes it variable. 
4.5 Other findings 
4.5.1 Pigmentation 
Chronic episodes of angle closure may leave patches of pigment at the level of contact, 
mostly at the trabecular meshwork, but, depending on the degree of apposition, the pigment 
clumps may be seen above Schwalbe’s line. Heavy, but diffuse, pigmentation of the 
trabecular meshwork is more typical of pigment dispersion syndrome and 
pseudoexfoliation. The presence of more diffuse and somewhat grey pigmentation above 
Schwalbe’s line is called Sampaolesi’s line, and is highly suggestive of pseudoexfoliation 
syndrome. It can be concurrent with ACG, especially when the zonules begin to become 
affected and the lens tends to move forward. Previous trauma is another cause of angle 
pigmentation, but it is usually accompanied by other more prominent signs, such as 
pupillary sphincter ruptures, angle recession or a cyclodialisis cleft, but it can also be 
confirmed by the subtle finding of disinserted or ruptured iris processes. 
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4.5.2 Iris processes 
Normal iris processes are fine strands of iris tissue that can reach the scleral spur, or even 
the posterior third of the trabecular meshwork. Long iris processes are more anterior and 
reach anterior portions of the trabecular meshwork. Iris tissue that reaches Schwalbe’s line is 
actually a defining feature of Axenfeld’s anomaly. 
4.5.3 Blood vessels 
Blood vessels may be a normal finding or a sign of disease. Normal blood vessels are 
usually circumferential and close to the scleral spur, but never above it. Abnormal vessels, 
on the other hand, are usually due to retinal hypoxia or some forms of uveitis. They cross 
over the scleral spur and will cover the trabecular meshwork, initially in segments. 
Neovessels will eventually interfere with aqueous outflow, and cause secondary angle 
closure due to peripheral anterior synechiae (PAS). Neovessels associated with Fuch’s 
heterochomic iridocyclitis tend to be finer, more fragile, and almost never reach beyond the 
trabecular meshwork or cause PAS.  
5. Angle exploration 
Gonioscopy is done to determine the anterior chamber angle characteristics such as the level 
of iris insertion, the shape of the peripheral iris, the width of the angle, the degree of 
trabecular pigmentation and areas of PAS or apposition. The anterior chamber angle can be 
evaluated by different techniques: van Herick technique, direct or indirect gonioscopy. 
(EUGS, 2009; Friedman & He, 2008). 
 
 
Fig. 1. Gonioscopy of open angle seen by three-mirrored Goldmann lens. Normal iris 
processes can be seen reaching the scleral spur.  
5.1 Van Herick grading 
Van Herick´s method is an integral part of eye examination and is used to describe the 
peripheral anterior chamber depth by using an oblique beam of light at the slit-lamp 
(Figures 2 and 3). The angle is considered as non-occludable when there is an space between 
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the endothelium and the anterior iris surface that measures at least one half of the peripheral 
corneal thickness (Table 1). (EUGS, 2009). 
 
 
Fig. 2. Van Herick´s method: Peripheral anterior chamber depth is evaluated with a 
narrowed slit-lamp beam angled at 60º, passing through the cornea at the limbus. This 
photograph shows an example of van Herick´s grade I. 
 
 
Fig. 3. This photograph shows an example of van Herick´s grade III, considered non-
occludable. 
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Van Herick´s method is easy to perform and correlates well with gonioscopy, (Wolfs et al., 
1997) but cannot replace it. If one uses the van Herick´s method like the only form of angle 
evaluation, important information will be missed about the anatomic appearance of angle 
structures, such as peripheral iris shape, the relationship between the anterior surface of the 
lens and the posterior surface of the iris, the number of angle structures that can be seen with 
or without indentation, the presence or absence of PAS and its extension, the changes in angle 
opening in dark/light conditions, among others. (Tasman & Jaeger. 2004; EUGS, 2009) 
 
Grade Characteristics 
0 Irido-corneal contact 
I 
Space between iris and corneal endothelium of < 1/4 of corneal 
thickness  
II When the space is > 1/4 < 1/2 of corneal thickness 
III 
Considered not occludable, with an irido-endothelial distance > 1/2 
corneal thickness 
Table 1. Van Herick´s grading system. 
5.2 Direct gonioscopy 
In direct gonioscopy, light from the anterior chamber passes through the cornea and 
through a contact goniolens, permitting a direct and adequately magnified view of angle 
structures, and making simultaneous comparison of both eyes possible. One of the most 
common goniolenses used for this technique is Koeppe´s contact goniolens. (Tasman W, 
Jaeger E. 2004; EUGS, 2009) 
5.3 Indirect gonioscopy 
In this technique light from the anterior chamber is reflected on a mirror, allowing an 
indirect (inverted) view of the anterior chamber angle. Indirect gonioscopy, in our point of 
view, must be performed in all glaucoma patients and suspects at least once a year. Indirect 
gonioscopy is the gold standard technique to categorize glaucoma suspects or patients into 
open or closed-angle categories.  There are two main types of lenses used for indirect 
gonioscopy: three-mirrored Goldmann type lens and the four-mirrored Posner type 
goniolenses. We consider four-mirrored lenses as ideal to perform excellent gonioscopy. 
These lenses have a contact surface that is smaller than the cornea, permitting indentation 
gonioscopy, have no need of lubricating agents, and permit faster viewing of four quadrants 
without rotating the lens. The three-mirror Goldmann lens facilitates application of laser 
(e.g. trabeculoplasty), but requires rotating the lens in order to view all quadrants at the 
same time and cannot be used for performing indentation gonioscopy.  Indentation 
gonioscopy must be done when van Herick´s grading is suggestive of angle-closure or the 
patient is being evaluated as an angle-closure glaucoma suspect. (Figures 4: A and B) 
5.4 Common classifications of the anterior chamber angle 
Gonioscopy grading systems are useful to record findings using a systematic approach. 
They help classify patients into open, occludable or closed angle varieties and also help 
comparing gonioscopic observations through time in the same eye.  There are two types of 
classification: simpler systems that only evaluate the degree of angle opening (Shaffer and 
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Scheie systems) and more comprehensive ones, such as Spaeth’s system, that also evaluates 
the level of iris insertion, iris configuration and extent of angle opening. The later is a bit 
more time consuming because of its sophistication, and might be difficult to perform on a 
demanding setting. (Friedman & He, 2008) 
 
 
Fig. 4. A. 
 
 
Fig. 4. B. 
Fig. 4. Indentation gonioscopy. Figure 4A: Angle viewed without indentation and figure 4B 
is the same angle with indentation, making the trabecular meshwork and the scleral spur to 
become visible. Notice the peripheral convexity of the iris during indentation and the 
peripheral anterior synechia that remains despite indentation. 
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For routine clinical evaluation we prefer Shaffer´s system, which evaluates the number of 
visible angle structures while maintaining the surface of the gonioscopic lens perpendicular 
to the observation axis, taking care to avoid inadvertently changing angle structures during 
examination. When a four-mirrored lens is used, indentation should be avoided at the 
beginning, in order to achieve a reliable exploration in primary position. Then dynamic 
indentation and dark/light gonioscopy should be performed in all cases being evaluated for 
narrow angles or when van Herick´s is suggestive of angle-closure, in order to verify the 
presence of PAS, or reproducible apposition of iris and trabecular structures (Figure 4). 
 
Grade Visible Structures Characteristics 
0 No angle structures are visible Angle closed 
1 Schwalbe´s line Angle-closure likely 
2 Schwalbe´s line and trabecular meshwork Angle-closure possible 
3 
Schwalbe´s line, trabecular meshwork, and 
scleral spur 
Angle-closure unlikely 
4 
Schwalbe´s line, trabecular meshwork, scleral 
spur and ciliary body band 
Angle-closure unlikely 
Table 2. Shaffer´s grading system. 
 
 
Fig. 5. This photograph illustrates the examination of the irido-lenticular channel using a 
narrow slit-lamp beam through a goniolens. In this example there is no irido-lenticular 
contact, made evident by a visible space between the light beam on the lens and that on the 
iris. 
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Scheie´s system is designed to describe closure, also based on the number of visible angle 
structures, so grade 0 corresponds to a wide open angle and 4 to a closed angle. Spaeth´s 
system uses angle grading in degrees, and also describes iris insertion (or apparent iris 
insertion) and configuration. All other findings should also be properly described, and their 
location and extension in clock-hours should also be noted. A drawing of all additional 
findings can prove to be very useful for long-term follow-up. 
Another characteristic of the anterior chamber that can be examined is the degree of irido-
lenticular contact. This can be evaluated with a narrow slit-lamp beam that passes through 
the lens and the pupil margin through a goniolens (Figure 5). 
6. Mechanisms of angle-closure 
There are two main mechanisms of primary angle-closure: Pupillary block and iris plateau. 
It is important to recognize them because pupillary block responds well to a laser peripheral 
iridotomy and plateau iris responds better to a laser peripheral iridotomy plus argon laser 
peripheral iridoplasty. (EUGS, 2009; Friedman, 2001; Polikoff et al., 2005; Tasman & Jaeger, 
2004) 
The predominant mechanism of acute angle-closure is pupillary block and represents 
around 75% of cases of primary angle-closure. In eyes with shallow anterior chamber, the 
more anterior position of the lens, in addition to greater anterior surface curvature, increases 
the area of contact of the posterior iris surface to the lens, facilitating a pressure differential 
between the anterior and posterior chambers that causes forward bowing of the relaxed, 
peripheral iris. Silver and Quigley (2004), explored the hypothesis that the differential 
pressure between the anterior and posterior chambers arises from the dynamics of aqueous 
flow across the iris-lens channel,  (Figure 5) estimating that the magnitude of the posterior to 
anterior pressure difference was greater with increases in channel length or aqueous inflow 
and with decreases in channel height or pupil diameter.  
In plateau iris, the anterior chamber depth appears to be normal, and the iris plane remains 
flat, but the angle looks narrow or closed due to the shape of the peripheral iris, which 
drops abruptly in the far periphery, making a narrow recess over the trabecular meshwork. 
The mechanisms that increase iridotrabecular contact are: thicker iris, anterior iris insertion 
and anterior position of the ciliary body. Eyes with plateau iris configuration may have 
angle-closure when the pupil is mydriatic due to iridotrabecular apposition.  
In plateau iris configuration, the associated relative pupillary block can be treated by a laser 
peripheral iridotomy. The term plateau iris syndrome is used whenever gonioscopy 
confirms angle-closure in the presence of a patent iridotomy. When performing indentation 
in these cases the iris can be pushed posteriorly, so it assumes a concave shape that follows 
the lens curvature, but the peripheral iris remains elevated due to the position of the ciliary 
processes. Treatment for these cases should be argon or diode laser iridoplasty, or 
permanent pilocarpine, if laser treatment is not available.  
Another mechanism participating in primary angle-closure is lens size and position. Eyes 
with a thicker and anteriorly positioned lens tend to have shallower anterior chambers. 
(George  et al.,2003). Zonular abnormalities due to congenital abnormalities (e.g. Marfan’s 
syndrome), trauma or even pseudoexfoliation, can also predispose to angle-closure in a 
previously deep anterior chamber. (Ritch & Schlötzer-Schrehardt, 2001; Dureau, 2008). 
Secondary causes of angle-closure, such as phacomorphic, uveitic and neovascular cases, 
need to be promptly identified in order to establish a specific treatment. 
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7. Angle-closure glaucoma suspect and risk factors  
Early identification of high-risk angle-closure suspects has the potential of delivering a very 
effective and timely preventive treatment (iridotomy). An angle-closure glaucoma suspect is 
a patient who has two or more quadrants of iridotrabecular contact in dark-room 
gonioscopy, normal intraocular pressure, without PAS and no damage to the optic nerve. 
These patients sometimes have transitory, but recurrent, morning symptoms, namely 
headache, eye pain, nausea, blurred vision and even halos around lights. 
Risks factors for primary angle-closure glaucoma include: demographic, anatomic, genetic 
and other external factors.  
7.1 Demographic risk factors 
The prevalence of primary angle-closure glaucoma varies among different populations. It is 
0.8% in the general Eskimo population (1.2% in women, and increases to 2.5% beyond 40 
years of age,  while in a general British population it is as low as 0.09%. Both prevalence and 
incidence data demonstrate that angle-closure affects East Asian people more frequently 
than European people. (Bonomi, 2000; George et al., 2003; Nathan et al. 2003; Yip & Foster, 
2006; Van Rens et al., 1988). 
Women are at greater risk for angle-closure glaucoma. Women have a shallower anterior 
chamber depth and have shorter axial length than men. A statistical model estimates that 
70% of people affected by angle-closure are women. The prevalence of all categories of 
angle-closure is 2-5 times higher in women than in men. (Quigley & Broman, 2006) 
Age is another important risk factor for developing angle-closure glaucoma. According to a 
population study, age varied between 40 and 60 years in angle-closure diagnosed patients. 
However there are other studies where a bimodal distribution was noticed, with the first peak 
of incidence between 53 and 58 years old and a second peak between 63 and 70 years old. 
Occludable-angle prevalence in Asian populations increases from 54.3 years, but the average 
for closed-angle glaucoma is 57.95 years; less than 4 years separate occludable angles from 
definite glaucoma. Older age is also related to a decrease in anterior chamber depth due to the 
thickening and anterior movement of the lens. (George et al., 2003; Quigley & Broman, 2006) 
7.2 Ocular anatomic characteristics 
Primary angle-closure glaucoma eyes have an average axial length about 1 mm shorter than 
normal eyes, making hyperopes more predisposed than emmetropes or myopes to angle-
closure glaucoma. Occludable angles, short eyes, shallower anterior chamber depth, thicker 
lenses, and a closer relationship between the lens and the posterior iris surface in a patient 
with acute angle-closure glaucoma are other anatomical risk factors that should also be 
sought in the fellow eye. Cross-sectional and clinical studies consistently find that smaller 
eyes with these characteristics are at higher risk for angle-closure. (George et al., 2003; 
Thomas et al., 2004) 
The contralateral eye of a patient with an acute angle-closure glaucoma is considered at risk 
of developing an acute attack, and a prophylactic peripheral iridotomy is recommended. If 
less than 180º of trabecular meshwork is visible on gonioscopy without indentation or if the 
angle closes in dark conditions, the risk of angle-closure glaucoma is also higher.  
Eyes with occludable angles are characterized by shorter axial lengths, and normal women 
have shorter eyes than men (22.07 mm vs. 22.58  mm respectively). In a similar way the 
proportion of lens thickness to axial length is significantly greater in this group of patients. 
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About 22% of occludable angles progress towards closed-angle glaucoma. (George et al., 
2003; Thomas et al., 2004) 
Some zonular diseases may be related to secondary angle-closure glaucomas, such as 
exfoliation syndrome, Marfan´s Syndrome and Weil-Marchesani Syndrome, among others. 
(Ritch & Schlötzer-Schrehardt, 2001; Dureau, 2008) 
7.3 Genetic and other external factors 
Similarities in ocular biometry in first-degree relatives of angle-closure patients, indicates 
that angle-closure related anatomical characteristics are at least partially heritable. The risk 
of developing angle-closure glaucoma was reported to be 3.5 times higher in first degree 
relatives of affected Inuit patients. In Chinese twins the heritability of anterior chamber 
depth and drainage angle width could be as high as 70–90%. (He, 2010) 
Pupillary dilation can induce angle-closure in very shallow anterior chambers, but in less 
shallow anterior chambers it can actually open the angle due to posterior displacement of 
the lens-iris diaphragm. Dilation can also induce pupillary block when the pharmacological 
effect is ebbing, especially when the pupil is at mid-mydriasis, at a time when the patients 
are probably going back home from consultation. The risk of an acute angle-closure attack is 
3 in 10,000 patients dilated if dapiprazole and pilocarpine are used for reverting mydriasis 
(Bonomi et al., 2000; Patel et al., 1995; Wolfs et al., 1997). Other systemic medications like 
antiparkinsonian drugs, tricyclic antidepressants, monoamine oxidase inhibitors, 
vasoconstrictors and anticholinergics in general may produce an acute angle-closure 
glaucoma attack in predisposed patients. (Lachkar & Bouassida, 2007). The use of two or 
more drugs, potentiates the mydriatic effect and the risk of an acute attack in predisposed 
eyes.   
8. Clinical diagnosis 
8.1 Prodromal symptoms  
These symptoms are caused by the sudden increase and decrease of intraocular pressure, 
when narrow angles close and reopen. Prodromic symptoms can be precipitated by 
mydriatic or miotic drops, dim light, prone or semi prone and sympathetic stimulation, so 
an acute attack is a matter of time. 
Patients with prodromal symptoms usually have mild to moderate morning headache, 
accompanied with nausea, blurred vision and rainbow-hued haloes around bright lights. 
Symptoms can be recurrent, but short-lived because the pupillary block is broken when 
light induces myosis on waking-up. 
8.2 Acute angle-closure glaucoma 
In acute angle-closure glaucoma, acute signs and symptoms become permanent and severe, 
especially when the rise in intraocular pressure is abrupt. 
Angle-closure is always present, the iris is in contact to the peripheral cornea and the 
trabecular meshwork. During the first few hours of an acute attack synechiae have not yet 
formed, but the longer the iris is against the angle, the risk for anterior synechia formation is 
higher and almost certain. Once this happens, the angle will no longer open with an 
iridectomy and trabecular outflow will be permanently affected.  
Blurred vision and haloes (with the blue-green component nearest the light source) around 
lights are due to aqueous that is forced into the corneal stroma, causing stretching of 
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collagen lamellae and, eventually, epithelial oedema. The cornea then becomes hazy and 
bullae may appear (Figure 6). 
 
 
Fig. 6. Corneal epithelial oedema in a patient with an acute angle-closure glaucoma. 
Mid-mydriasis: Paralysis and ischemia of the pupillary sphincter are caused by the increase 
in intraocular pressure, causing a fixed mid-dilated pupil.  
Venous congestion: This occurs when intraocular pressure exceeds that of episcleral veins. 
Iris blood vessels become dilated and also the veins in the conjunctiva, giving the patient a 
painful red eye (Figure 7). 
Sector atrophy of the iris: The abrupt increase in intraocular pressure causes an interruption 
of the arterial supply to the iris, resulting in ischemia which causes damage to the iris, 
leaving behind patches of stromal atrophy (Figure 8). 
Aqueous flare: Due to vascular congestion, proteins leak out into the anterior chamber, usually 
causing mild aqueous flare. Pigment particles can also be seen in the aqueous humor, and can 
eventually be found deposited on the endothelium and on the iris surface. 
Glaukomflecken:  Small, multiple, irregular or patchy, gray-dot opacities are areas of ischemia 
of the anterior capsule epithelium secondary to the increase in intraocular pressure (Figure 9). 
They can be at different depths from the anterior capsule, indicating a chronology of previous 
attack. Once an iridotomy is patent and recurrent attacks are prevented, lens growth will bury 
glaukomflecken spots under newer, transparent layers of lens epithelial cells. 
Autonomic Stimulation: nausea and vomiting may accompany the acute angle-closure 
attack, sometimes complicating the diagnosis. The oculocardiac reflex produces bradycardia 
and there is often profuse sweating. 
Disc and field changes: the optic nerve head can be seen hyperemic due to venous 
congestion and edematous within 24 hours of the rise in intraocular pressure. Field changes 
may be difficult to document due to the intense pain, corneal changes and decreased vision 
during an acute attack, but field constriction has been shown and an important decrease in 
vision might become permanent if the pressure remains elevated. Visual symptoms and 
vision abnormalities usually improve, once pressure is normalized.  
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Synechiae: The iris is pushed against the trabecular meshwork during the first hours of an 
angle-closure attack. An iridotomy will break the attack and separate the iris from the 
trabecular meshwork. If the attack is not promptly broken, iris congestion and inflammation 
will promote the formation of peripheral anterior synechiae, which might become permanent, 
and even cause posterior synechiae formation. (Tasman & Jaeger, 2004; Yanoff & Duker 2004). 
 
 
Fig. 7. Ciliary and conjunctival vessel congestion in a patient with an acute attack of angle-
closure glaucoma. 
 
 
Fig. 8. Sector iris atrophy. The pupil might remain in a fixed position, usually mid-
mydriasis. 
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Fig. 9. Multiple gray dot like opacities behind the anterior capsule, glaukomflecken. 
8.3 Chronic angle-closure glaucoma 
This type of presentation occurs when angle-closure is gradual, or “creeping”. The area of 
contact between the iris and trabecular meshwork increases silently, and gradually. 
Intraocular pressure begins to rise and since this rise is gradual, the patient might not have 
any symptoms. 
During an examination, the angle is occluded or occludable in most of its circumference 
(Figure 8), decreasing outflow facility, elevating IOP and consequently developing cupping, 
field defects and vision loss.  
PAS also form in this type of angle-closure, because the iris is in chronic contact with the 
trabecular meshwork. Before PAS form, signs of iris and trabecular meshwork contact can 
be seen, such as clumps of pigment on the trabecular meshwork or areas of contact that can 
be opened by pressing on the cornea with a goniolens. 
9. Other diagnostic techniques 
Modern ultrasound and optical techniques are now available, that contribute to the 
understanding of anatomical mechanisms participating in angle-closure. 
Ultrabiomicroscopy is a relatively new technique developed in 1990 by Pavlin and Foster. It 
is a very high frequency ultrasound (50-80 MHz) that allows visualization of anterior 
segment structures with a lateral resolution of 50 microns and an axial resolution of 20 
microns. It can obtain images of the ciliary body, zonule, lens, iris, angles, anterior chamber 
and cornea. Higher frequencies (100 MHz) have been developed enabling Schlemm´s canal 
to be evaluated (iScience surgical). It is possible to analyze the in vivo mechanisms of 
interaction among anterior segment structures. Ritch et al. have used ultrabiomicrocopy to 
identify four possible anatomic sites of origin of angle-closure glaucoma: the iris (pupillay 
block), the ciliary body (plateau iris), the lens (phacomorphic glaucoma) and posterior to the 
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lens (malignant glaucoma). Ultrabiomicroscopy is also useful in evaluating secondary angle-
closure glaucomas, such as those caused by iridociliary cysts, lens subluxation or 
microspherophakia.    
Anterior segment optical coherence tomography is a non-contact, optical instrument that 
uses a wavelength of 1310 nm and permits acquisition of images of anterior segment with a 
transverse resolution of 60 microns and an axial resolution of 10-20 microns. It has the 
disadvantage of light absorption by the sclera and iris, so structures such as the ciliary body 
and the iris-anterior capsule interaction are not visible.  Even though the scleral spur is 
harder to detect by anterior segment optical coherence tomography in open and closed 
angles, a quantitative analysis of the angle is still possible. Spectral domain or Fourier 
optical coherence tomography uses a shorter wavelength of 830 nm, that allows a higher 
resolution with shorter penetration in tissues. Images of Schwalbe’s line, trabecular 
meshwork and Schlemm´s canal can be obtained.   
The Pentacam-Sheimpflug camera is a non-contact high resolution imaging system that 
constructs a 3 dimensional image of anterior segment. Angle analysis is subjective, once the 
user places markers on the endothelium and the iris plane. Measures in closed angles have a 
limited correlation with gonioscopy and ultrabiomicroscopy.   
10. Treatment 
Angle-closure glaucoma treatment options are: medical, laser and surgical (table 3). 
Treatment in all types of angle-closure glaucoma should be directed towards reduction of 
intraocular pressure, reopening the angle and preventing and/or stopping optic nerve 
damage. Indications for each treatment modality vary depending on clinical presentation, 
but more than one might be needed in an individual patient. In the case of acute angle-
closure glaucoma, defining the mechanisms that are participating in the pathogenesis of the 
event, such as pupillary block, PAS, non-pupillary block or coexistence of all, will lead us to 
decide initial management.   
 
 
Medical treatment Laser treatment Surgical treatment 
Pilocarpine 
 
Hyperosmotic agents 
(glycerin and mannitol) 
 
Carbonic anhydrase inhibitors 
 
Alpha agonists 
 
Prostaglandin analogs 
 
Beta blockers 
Argon laser peripheral 
iridotomy 
 
Argon laser iridoplasty 
 
Argon laser iridotomy 
 
Nd:YAG iridotomy 
Anterior chamber 
paracentesis 
 
Iridectomy 
 
Lens/cataract extraction 
 
Filtering surgeries 
 
Cyclodestructive surgeries 
 
 
 
Table 3. Treatment options for angle-closure glaucoma. 
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10.1 Medical treatment 
Initial approach of a patient with acute angle-closure glaucoma with pupillary block is 
medical in most cases. The goals are to lower IOP, alleviate pain, and clear the cornea so an 
iridotomy can be safely made. It is important to indicate drugs that will lower intraocular 
pressure in a short period of time.  
10.1.1 Hyperosmotic agents 
Hyperosmotic agents act by creating an osmotic differential between blood vessels and 
extravascular tissues, thus they are thought to work by dehydrating the vitreous, reducing its 
volume, and lowering intraocular pressure. They start acting 10 to 20 minutes after being 
administered, reach their peak action an hour later. The effect lasts for approximately 5 hours.   
Some of them are administered orally (glycerol and isosorbide) and others like mannitol 
need intravenous administration (table 4). It is important to consider that if a patient has 
nausea and vomit, glycerol and isosorbide might not be tolerated. Side effects of glycerol 
and isosorbide include: diuresis, nausea, vomit, headache, backache, diarrhoea and fever. 
Other class side effects (including mannitol) are: cardiovascular overload, intracranial 
haemorrhage, pulmonary oedema, renal insufficiency and metabolic acidosis. Some 
systemic conditions like diabetes, arterial hypertension, cardiac and prostatic diseases, 
should be kept in mind when a patient is receiving hyperosmotic agents, since side effects in 
those cases can be especially harmful.  
Mannitol tends to form fine crystalline precipitates in cold solutions. If this occurs, the 
solution can be heated and used. 
 
Drug Dose 
Glycerol  1-1.5 g per kg of body weight in a 50% oral solution 
Isosorbide 1.5 g per kg of body weight in a 50% oral solution 
Mannitol 
1-2 g per kg of body weight in a 20% solution. Intravenous rate of 
3-5 mL per minute 
Table 4. Hyperosmotic agent doses for acute angle-closure glaucoma. 
10.1.2 Systemic carbonic anhydrase inhibitors 
Carbonic anhydrase is an enzyme that catalyzes the hydration of carbon dioxide and 
dehydration of carbonic acid. The inhibition of this enzyme (specifically its isoenzyme II 
form) in the ciliary processes reduces production of aqueous humor. Maximum effect in 
lowering intraocular pressure occurs 2 hours after the initial dose. Acetazolamide has oral 
and injectable formulations. Systemic side effects include: paresthesias, taste alterations, loss 
of appetite, headaches, diarrhoea, nausea, vomit, hypokalemia and metabolic acidosis. Rare 
side effects include Steven-Johnson syndrome aplastic anemia and urolithiasis. Its use is 
contraindicated in patients allergic to sulfonamides, patients with sickle cell anemia, those 
with renal failure and Addison´s disease. Patients with diabetes, hepatic insufficiency and 
chronic obstructive pulmonary disease have to be closely observed when taking 
acetazolamide, since metabolic acidosis can worsen their systemic conditions. 
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Drug Dose 
Acetazolamide 125 to 250 mg every 6-8 hrs 
Methazolamide 25 to 100 mg every 12 hours 
Table 5. Systemic carbonic anhydrase inhibitors dose. 
10.1.3 Cholinergic agents 
Parasympathomimetic drugs, such as pilocarpine, act in muscarinic receptors (M3) of the 
iris sphincter muscle, causing it to contract and inducing myosis. It also induces contraction 
of the longitudinal ciliary muscle, which improves trabecular meshwork opening. 
Pilocarpine is also used for preparing a patient for laser iris treatment, because it makes the 
iris thinner and facilitates iridotomies, and improves visualisation of peripheral iris for 
iridoplasty. Pilocarpine is also useful as a temporary treatment in cases of plateau iris 
syndrome, previous to iridoplasty. 
The intraocular pressure lowering effect starts within 2 hours of instillation. Pilocarpine 
dosing for acute angle-closure is shown in table 6. The use of pilocarpine carries the risk of 
side effects that worsen the clinical symptoms in angle-closure glaucoma. Caution must be 
taken in eyes with very high intraocular pressure, since receptors of the ischemic iris 
sphincter muscle become unresponsive to the drug, although ciliary muscle contraction 
causes anterior displacement of the lens diaphragm, shallower anterior chamber depth and 
worsening of the clinical picture. Pilocarpine must also be avoided in cases where the 
mechanism of angle-closure is lens induced, as in phacomorphic or pseudoexfoliation 
glaucomas, and in cases where the mechanism is aqueous misdirection, as in malignant 
glaucomas. It should not be used for secondary angle-closure glaucomas, such as 
neovascular glaucoma, because of the risk of hyphema and inflammation. Other side effects 
are: myopia, aggravation of a pre-existing iritis or ocular inflammation, and an increase on 
the risk of rhegmatogenous retinal detachment.  
 
 
Drug Dose 
Pilocarpine (2%, 4%) 
1 drop every 5 minutes, 2 doses in the acute phase 
Repeat dose every 2-3 hours until iridotomy is performed 
 
Table 6. Pilocarpine dose in acute angle-closure glaucoma. 
10.1.4 Beta-blockers  
They act by reducing the production of aqueous humor. Whether selective or not, beta-
blockers lower IOP by about 20-40%. Systemic side effects are: bronchoconstriction, 
masquerading of signs and symptoms of hypoglycemia, bradycardia, lowering cardiac 
output, auriculo-ventricular block, systemic hypotension. The usual topical dosing is shown 
in table 7. 
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Drug Dose 
Timolol, Carteolol, Levobunolol, Metipranolol 
and Betaxolol 
1 drop every 12 hours 
Table 7. Beta blockers dose in acute and chronic angle-closure glaucoma. 
10.1.5 Alpha 2 agonists  
Adrenergic receptors in the eye are located in the iris and ciliary body muscle and 
epithelium, retina and retinal pigment epithelium. The intraocular pressure lowering effect 
of these drugs has a dual mechanism: by lowering aqueous production and by increasing 
aqueous outflow though the uveoscleral pathway. The mydriatic effect of these drugs and 
the possibility of worsening angle-closure do not exceed their benefit in lowering intraocular 
pressure in an acute attack of angle-closure. Epinephrine and dipivalyl epinephrine are 
contraindicated in cases of occludable angles. Brimonidine and apraclonidine are equally 
efficient in preventing IOP elevation after anterior segment laser procedures like iridotomy 
or trabeculoplasty (Chen et al., 2001).  
10.1.6 Prostaglandin analogues 
Prostaglandin analogues latanoprost, travoprost and bimatoprost, are drugs than enhance 
the aqueous uveoscleral outflow in healthy and glaucomatous eyes. Its use in the acute 
attack of angle-closure glaucoma is not recommended but they have been proved effective 
in lowering the intraocular pressure in eyes with previous patent iridotomy or in chronic 
angle-closure glaucoma. The presence of PAS or anatomical changes of the ciliary body or 
the degree of angle narrowing or closure, have not proved to alter the efficacy of 
prostaglandin analogues for lowering intraocular pressure. (Aung et al., 2005) 
10.1.7 Other manoeuvres 
Other measures taken in cases of acute angle-closure glaucoma in which weak zonular fibers 
or a lens mediated elevation of intraocular pressure are participating, include supine 
positioning of the patient and corneal indentation, that will allow the lens to move 
backwards improving in some cases the passage of aqueous humor from posterior to the 
anterior chamber. Topical anti-inflammatory drops are also useful. 
Once the acute attack is relieved, and iridotomy is performed, long-term medical treatment 
can be indicated to avoid further damage of the optic nerve.  
10.2 Laser treatment 
Once medical therapy has achieved IOP lowering and corneal oedema has improved, a careful 
examination of the angle and optic nerve is recommended.  Iridotomy should be performed in 
all types of primary angle-closure glaucoma in order to alleviate pupillary block, avoid future 
acute attacks and lower intraocular pressure (Figure 10). Anterior chamber central depth does 
not change after an iridotomy, but the periphery does become deeper, the iris assumes a more 
planar configuration, closer to the anterior lens capsule and equator, and the iridocorneal 
angle widens, reducing the risk of PAS development. The contralateral eye should also be 
evaluated and a prophylactic iridotomy considered. (Friedman, 2001; Gazzard et al., 2003; 
Hsiao et al., 2003; Kashiwagi et al., 2004; Lim et al., 2004) 
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Japanese patients with iridotomies and a mean follow-up of 5.8 years showed that 50% of 
eyes with acute attack and 14% of contralateral eyes required topical treatment after 
iridotomy to control intraocular pressure. About 46% of patients with chronic angle-closure 
glaucoma required topical treatment after iridotomy for the same purpose. Additionally that 
study showed that 18% of eyes that had had an acute attack of angle-closure glaucoma and 
were receiving topical treatment and iridotomy, still required trabeculectomy to adequately 
control intraocular pressure. (Aung et al., 2001; Hsiao et al., 2003; Kashiwagi et al, 2004). 
Iridotomy in plateau iris, produces no significant changes in anterior chamber depth, or the 
distance between the trabecular meshwork and ciliary body, iris thickness, angle opening 
distance at 500 microns, or the distance between the trabecular meshwork and iris, but it 
does decrease iridozonular distance and any relative pupillary block. 
In a study of 90 Asian patients who had had an angle-closure attack with a mean 6.3 years of 
follow up, blindness was present in 17.8% of the affected eyes, 50% had demonstrable optic 
nerve glaucomatous damage, and visual acuity was also decreased in a large proportion of 
patients, mainly because of cataract.  (Aung et al., 2004) 
 
 
Fig. 10. Peripheral laser iridotomy. 
Visual fields performed during an attack reveal generalized or mixed defects that may be 
reversible. Most defects fall in the 9 to 21 degree area, with a tendency towards superior 
locations. A decrease in the nerve fiber layer can also be shown and occurs mainly at the 
poles. Damage tends to be more severe in eyes that initially present with an acute attack of 
angle-closure glaucoma. (Bonomi et al.,1999; Aung et al., 2004) 
Peripheral iridoplasty (Figure 11) has proved to be more effective in lowering IOP than 
medical therapy during the first two hours of an acute attack, but it can be impossible to 
achieve if corneal opacity is present. (Lam, Et. al. 2002) It is considered as the first line of 
treatment for patients with plateau iris syndrome, effectively controlling IOP as long as PAS 
are not present. Lasers and indications used are described in table 8. 
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Fig. 11. Peripheral laser iridoplasty, note the greyish burn marks in the periphery, and a 
patent infero-temporal iridotomy. 
 
Procedure Laser used Indications 
Iridotomy Nd:YAG 
Argon 
Sequential argon-ND:YAG 
Occludable angle 
Contralateral eye of an acute ACG 
Narrow or closed angle in more than 180 degrees 
with optic nerve damage and high IOP 
Acute ACG 
Peripheral 
Iridoplasty 
Argon Plateau iris 
In preparation for laser trabeculoplasty 
After iridotomy if iris apposition is still present 
Before an iridotomy, in cases of thick, inflamed 
or rubeotic irises. 
 
Table 8. Laser treatment  
Complications that can be found as consequence of laser treatment are: IOP peaks, 
inflammation, failure of the iridotomy, diplopia, bleeding, cataract, corneal trauma, retinal 
burns, malignant glaucoma, lens-induced uveitis and rare cases recurrence of herpetic 
keratouveitis (Hou C et al, 2004), Charles Bonnet syndrome (formed visual hallucinations) (Tan 
et al, 2004) and choroidal effusion, especially if iridotomy is performed with an argon laser. 
10.3 Surgical treatment 
Surgery can be indicated for the acute angle-closure glaucoma attack whenever medical and 
laser treatment have failed to control IOP, when medical treatment is contraindicated and 
when there is poor cooperation during laser treatment. 
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In chronic angle-closure glaucomas indications for surgical treatment also include sub-
optimal IOP control with medical and laser treatment, and the presence of media opacities 
such as cataract.  
10.3.1 Iridectomy 
Although laser iridotomy has proved to have less complications than surgical iridectomy, 
this procedure is still useful when the cornea is not clear enough for laser treatment and in 
some cases of secondary angle-closure glaucoma. A surgical iridectomy should also be 
considered in ocular inflammatory diseases.  Spencer et al. (2011) found a low rate of success 
of laser iridotomy in eyes with uveitis and iris bombe, with a mean time to failure of 85 
days.  
10.3.2 Other surgical options 
Some authors have suggested other therapeutic measures such as paracentesis of the 
anterior chamber with a 15 ° knife to produce a self-sealing wound, alleviate pain, and clear 
the cornea for iridotomy. However this technique is invasive and the number of reported 
patients is small, and should not be considered as a first option in the treatment of this entity 
(Lam et al. 2002).  
Removal of the lens by phacoemulsification has also been advocated as a treatment option. 
In a prospective study patients in whom IOP had been partially lowered with medical 
therapy, phacoemulsification with intraocular lens implantation was performed, and IOP 
had lowered to a mean 12 mmHg by postoperative day seven, however this is a small 
sample with a short follow-up time. (Ming Zhi et al., 2003). 
Initial trabeculectomy has also been studied, reporting a decent success rate, but with a 
greater incidence of complications due to operating on an inflamed eye. This increased risk 
of complications should be taken into account when deciding on trabeculectomy. (Aung et 
al., 2000) 
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